Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122287533 | 12228753 | 3 | F | 201503 | 20160719 | 20160401 | 20160728 | EXP | US-JNJFOC-20160303953 | JANSSEN | 83.34 | YR | E | M | Y | 0.00000 | 20160728 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122287533 | 12228753 | 1 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 AND 15 MG | Y | N | UNKNOWN;UNKNOWN | 0 | TABLET | ||||||
| 122287533 | 12228753 | 2 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 AND 15 MG | Y | N | UNKNOWN;UNKNOWN | 0 | TABLET | ||||||
| 122287533 | 12228753 | 3 | SS | XARELTO | RIVAROXABAN | 1 | Oral | 20 AND 15 MG | Y | N | UNKNOWN;UNKNOWN | 0 | TABLET | ||||||
| 122287533 | 12228753 | 4 | PS | XARELTO | RIVAROXABAN | 1 | Oral | 20 AND 15 MG | Y | N | UNKNOWN;UNKNOWN | 202439 | TABLET | ||||||
| 122287533 | 12228753 | 5 | SS | ASPIRIN. | ASPIRIN | 1 | Oral | Y | 0 | TABLET | |||||||||
| 122287533 | 12228753 | 6 | SS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | Y | 0 | UNSPECIFIED | |||||||||
| 122287533 | 12228753 | 7 | C | PROTONIX | PANTOPRAZOLE SODIUM | 1 | Unknown | 0 | UNSPECIFIED |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122287533 | 12228753 | 1 | Atrial flutter |
| 122287533 | 12228753 | 2 | Thrombosis prophylaxis |
| 122287533 | 12228753 | 3 | Cerebrovascular accident prophylaxis |
| 122287533 | 12228753 | 4 | Atrial fibrillation |
| 122287533 | 12228753 | 5 | Product used for unknown indication |
| 122287533 | 12228753 | 6 | Product used for unknown indication |
| 122287533 | 12228753 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122287533 | 12228753 | HO |
| 122287533 | 12228753 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122287533 | 12228753 | Angina pectoris | |
| 122287533 | 12228753 | Coagulopathy | |
| 122287533 | 12228753 | Gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122287533 | 12228753 | 1 | 20150220 | 20150320 | 0 | |
| 122287533 | 12228753 | 2 | 20150220 | 20150320 | 0 | |
| 122287533 | 12228753 | 3 | 20150220 | 20150320 | 0 | |
| 122287533 | 12228753 | 4 | 20150220 | 20150320 | 0 |